These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
382 related articles for article (PubMed ID: 34242687)
1. Minimal Change Disease With Severe Acute Kidney Injury Following the Oxford-AstraZeneca COVID-19 Vaccine: A Case Report. Leclerc S; Royal V; Lamarche C; Laurin LP Am J Kidney Dis; 2021 Oct; 78(4):607-610. PubMed ID: 34242687 [TBL] [Abstract][Full Text] [Related]
2. Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine. Lebedev L; Sapojnikov M; Wechsler A; Varadi-Levi R; Zamir D; Tobar A; Levin-Iaina N; Fytlovich S; Yagil Y Am J Kidney Dis; 2021 Jul; 78(1):142-145. PubMed ID: 33839200 [TBL] [Abstract][Full Text] [Related]
3. Pediatric Minimal Change Disease and AKI following the Pfizer-BioNTech COVID-19 Vaccine: causal or incidental correlation? Annicchiarico Petruzzelli L; Minale B; Serio V; De Luca A; Marino Marsilia G; Campione S; Diomedi Camassei F; D'Arcangelo R; Luongo I; Lepore L; Giannattasio P; Molino D; Pirro L; Lonardo MC; Malgieri G; Pecoraro C G Ital Nefrol; 2022 Dec; 39(6):. PubMed ID: 36655832 [TBL] [Abstract][Full Text] [Related]
4. Minimal change disease following the Moderna COVID-19 vaccine: first case report. Thappy S; Thalappil SR; Abbarh S; Al-Mashdali A; Akhtar M; Alkadi MM BMC Nephrol; 2021 Nov; 22(1):376. PubMed ID: 34763669 [TBL] [Abstract][Full Text] [Related]
5. Relapse of minimal change disease following the third mRNA COVID-19 vaccination: a case report and literature review. Teragaki M; Tanaka M; Yamamoto H; Watanabe T; Takeoka J; Fukumi A; Maeda K; Takami Y; Saita H; Iwanari S; Ikeda M; Takeoka H CEN Case Rep; 2024 Feb; 13(1):53-58. PubMed ID: 37244881 [TBL] [Abstract][Full Text] [Related]
6. Sustained COVID-19 vaccine willingness after safety concerns over the Oxford-AstraZeneca vaccine. Sønderskov KM; Dinesen PT; Østergaard SD Dan Med J; 2021 Mar; 68(5):. PubMed ID: 33870886 [TBL] [Abstract][Full Text] [Related]
7. New-onset Nephrotic Syndrome after Janssen COVID-19 Vaccination: a Case Report and Literature Review. Lim JH; Han MH; Kim YJ; Kim MS; Jung HY; Choi JY; Cho JH; Kim CD; Kim YL; Park SH J Korean Med Sci; 2021 Aug; 36(30):e218. PubMed ID: 34342187 [TBL] [Abstract][Full Text] [Related]
8. De Novo Minimal Change Disease following Vaccination with the Pfizer/BioNTech SARS-CoV-2 Vaccine in a Living Kidney Donor. Marinaki S; Kolovou K; Liapis G; Skalioti C; Tsiakas S; Boletis I Medicina (Kaunas); 2021 Dec; 58(1):. PubMed ID: 35056345 [TBL] [Abstract][Full Text] [Related]
9. Minimal Change Disease After First Dose of Pfizer-BioNTech COVID-19 Vaccine: A Case Report and Review of Minimal Change Disease Related to COVID-19 Vaccine. Hanna J; Ingram A; Shao T Can J Kidney Health Dis; 2021; 8():20543581211058271. PubMed ID: 34804557 [TBL] [Abstract][Full Text] [Related]
10. Minimal change disease and acute kidney injury following the Pfizer-BioNTech COVID-19 vaccine. D'Agati VD; Kudose S; Bomback AS; Adamidis A; Tartini A Kidney Int; 2021 Aug; 100(2):461-463. PubMed ID: 34000278 [No Abstract] [Full Text] [Related]
11. Exacerbation of Minimal Change Disease Following mRNA COVID-19 Vaccination. Pirzadeh A; Emami S; Zuckerman JE; Nobakht N Am J Case Rep; 2023 Nov; 24():e941621. PubMed ID: 37941318 [TBL] [Abstract][Full Text] [Related]
12. Clinical features of acute kidney injury in patients with nephrotic syndrome and minimal change disease: a retrospective, cross-sectional study. Lin SP; Zhu FG; Meng JL; Sun XW; Cui J; Liang S; Yin Z; Sun XF; Cai GY Chin Med J (Engl); 2020 Nov; 134(2):206-211. PubMed ID: 33443939 [TBL] [Abstract][Full Text] [Related]
13. Acute Kidney Injury after First Dose of AstraZeneca COVID-19 Vaccine Managed in a Nigerian Hospital. Onukak AE; Akpan EE; Udo AIA; Kalu MK West Afr J Med; 2022 Jul; 39(7):769-771. PubMed ID: 35929534 [TBL] [Abstract][Full Text] [Related]
14. Impact of acute kidney injury on coagulation in adult minimal change nephropathy. Huang MJ; Wei RB; Su TY; Wang Y; Li QP; Yang X; Lv XM; Chen XM Medicine (Baltimore); 2016 Nov; 95(46):e5366. PubMed ID: 27861367 [TBL] [Abstract][Full Text] [Related]
15. IgA nephropathy relapse following COVID-19 vaccination treated with corticosteroid therapy: case report. Watanabe S; Zheng S; Rashidi A BMC Nephrol; 2022 Apr; 23(1):135. PubMed ID: 35392838 [TBL] [Abstract][Full Text] [Related]
16. ANCA-Associated Vasculitis Following Pfizer-BioNTech COVID-19 Vaccine. Shakoor MT; Birkenbach MP; Lynch M Am J Kidney Dis; 2021 Oct; 78(4):611-613. PubMed ID: 34280507 [TBL] [Abstract][Full Text] [Related]
17. A case of acute tubulointerstitial nephritis following administration of the Oxford-AstraZeneca COVID-19 vaccine: a case report. Williams SBM; Holwill SDJ; Clissold RL; Bingham C BMC Nephrol; 2023 Mar; 24(1):52. PubMed ID: 36918813 [TBL] [Abstract][Full Text] [Related]
19. Minimal change disease (MCD) following vaccination with ChAdOx1 nCoV-19 vaccine in a young Indian male: A case report. Krishna A; Singh PP; Mazumdar P; Sharma A J Family Med Prim Care; 2022 Oct; 11(10):6568-6570. PubMed ID: 36618145 [TBL] [Abstract][Full Text] [Related]
20. Renal Biopsy Diagnosis of Acute Tubular Injury after Pfizer-BioNTech COVID-19 Vaccination: A Case Report. Soma Y; Kitaji D; Hoshino K; Sunohara S; Iwano T; Kawano N Vaccines (Basel); 2023 Feb; 11(2):. PubMed ID: 36851341 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]